MeSH term
Frequency | Condition_Probility | Amino Acid Substitution | 3 | 0.0 |
Animals | 18 | 0.0 |
COS Cells | 2 | 0.0 |
*Cell Cycle Proteins | 36 | 2.0 |
Cell Line | 13 | 0.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
Fanconi Anemia/genetics/*metabolism | 2 | 50.0 |
Hela Cells | 5 | 0.0 |
Humans | 52 | 0.0 |
Macromolecular Substances | 4 | 0.0 |
Mutation, Missense | 2 | 0.0 |
Protein Binding | 9 | 0.0 |
Research Support, Non-U.S. Gov't | 40 | 0.0 |
Structure-Activity Relationship | 2 | 0.0 |
Apoptosis | 4 | 0.0 |
DNA Damage | 6 | 0.0 |
DNA Repair | 5 | 0.0 |
*DNA-Binding Proteins | 20 | 1.0 |
Models, Biological | 5 | 0.0 |
Mutation | 8 | 0.0 |
*Nuclear Proteins | 25 | 1.0 |
Oxidative Stress | 2 | 0.0 |
Oxygen/metabolism | 2 | 0.0 |
Proteins/genetics | 4 | 0.0 |
Female | 12 | 0.0 |
Male | 12 | 0.0 |
Nuclear Proteins/metabolism | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 27 | 0.0 |
Alleles | 2 | 0.0 |
Cells, Cultured | 2 | 0.0 |
Flow Cytometry | 2 | 0.0 |
Immunoblotting | 2 | 0.0 |
Mice | 9 | 0.0 |
Mitosis | 2 | 0.0 |
Phosphorylation | 6 | 0.0 |
Radiation, Ionizing | 3 | 2.0 |
Time Factors | 2 | 0.0 |
DNA-Binding Proteins/*genetics | 3 | 0.0 |
Fanconi Anemia/genetics | 2 | 16.0 |
Gamma Rays | 3 | 1.0 |
Genetic Complementation Test | 12 | 2.0 |
Hamsters | 2 | 0.0 |
Mitomycin/pharmacology | 8 | 8.0 |
Mutation/*genetics | 2 | 0.0 |
Ultraviolet Rays | 2 | 0.0 |
Comparative Study | 5 | 0.0 |
DNA Primers | 2 | 0.0 |
Fanconi Anemia/*genetics/physiopathology | 2 | 66.0 |
Genetic Vectors/genetics | 2 | 0.0 |
Signal Transduction/physiology | 2 | 0.0 |
Cell Line, Transformed | 6 | 0.0 |
Mice, Knockout | 6 | 0.0 |
Proteins/*genetics/physiology | 2 | 2.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
Cell Cycle | 2 | 0.0 |
Child | 4 | 0.0 |
English Abstract | 3 | 0.0 |
Genetic Predisposition to Disease | 3 | 0.0 |
Amino Acid Sequence | 4 | 0.0 |
Apoptosis/drug effects | 3 | 0.0 |
Fanconi Anemia/*genetics | 9 | 19.0 |
Molecular Sequence Data | 5 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Protein Processing, Post-Translational | 2 | 0.0 |
Trans-Activators/metabolism | 2 | 0.0 |
Tumor Necrosis Factor-alpha/pharmacology | 3 | 0.0 |
*Apoptosis | 2 | 0.0 |
Binding Sites | 3 | 0.0 |
Fanconi Anemia/*metabolism | 4 | 33.0 |
Proteins/genetics/*metabolism | 4 | 0.0 |
Recombinant Fusion Proteins/genetics/metabolism | 2 | 0.0 |
Tumor Cells, Cultured | 5 | 0.0 |
Proteins/*genetics/metabolism | 4 | 1.0 |
Genetic Vectors | 2 | 0.0 |
Retroviridae/genetics | 3 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Bone Marrow Cells/metabolism | 2 | 2.0 |
Fanconi Anemia/*genetics/pathology | 2 | 40.0 |
*Gene Expression Regulation | 2 | 0.0 |
Transfection | 6 | 0.0 |
Fanconi Anemia/*genetics/metabolism | 4 | 50.0 |
Proteins/*metabolism | 2 | 0.0 |
Acute Disease | 2 | 0.0 |
Adult | 4 | 0.0 |
Middle Aged | 3 | 0.0 |
Cross-Linking Reagents/pharmacology | 2 | 1.0 |
DNA Mutational Analysis | 6 | 0.0 |
DNA, Neoplasm/genetics | 2 | 0.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
Gene Deletion | 3 | 0.0 |
Homozygote | 2 | 0.0 |
Nuclear Proteins/*genetics | 2 | 0.0 |
*Signal Transduction | 2 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 4 | 0.0 |
Nuclear Proteins/genetics/metabolism | 2 | 1.0 |
Precipitin Tests | 4 | 0.0 |
Protein Biosynthesis | 2 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Binding Sites/genetics | 2 | 0.0 |
Cell Nucleus/metabolism | 4 | 0.0 |
Plasmids | 2 | 0.0 |
Two-Hybrid System Techniques | 3 | 0.0 |
Genes, Reporter | 2 | 0.0 |
Family Health | 2 | 0.0 |
Japan | 2 | 0.0 |
*Mutation | 6 | 0.0 |
Pedigree | 2 | 0.0 |
Saccharomyces cerevisiae/genetics | 2 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Base Sequence | 3 | 0.0 |
DNA-Binding Proteins/*genetics/metabolism | 2 | 0.0 |
Gene Expression Regulation | 3 | 0.0 |
Repressor Proteins/*genetics/metabolism | 2 | 3.0 |
Transcription Factors/*genetics/metabolism | 2 | 0.0 |
Adolescent | 2 | 0.0 |
Colony-Forming Units Assay | 2 | 0.0 |
*Gene Therapy | 2 | 0.0 |
Proteins/*genetics | 5 | 0.0 |
Cross-Linking Reagents/*pharmacology | 2 | 8.0 |
Proteins/genetics/*physiology | 2 | 1.0 |
Phenotype | 4 | 0.0 |
Exons | 3 | 0.0 |
Introns | 3 | 0.0 |
Models, Genetic | 2 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
Nuclear Proteins/genetics | 3 | 1.0 |
Transplantation, Isogeneic | 2 | 7.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Case-Control Studies | 2 | 0.0 |
Sequence Deletion | 2 | 0.0 |
Aged | 2 | 0.0 |
Genotype | 3 | 0.0 |
*Genes, BRCA2 | 2 | 0.0 |
Jews/*genetics | 2 | 1.0 |
Fanconi Anemia/*genetics/metabolism/pathology | 2 | 66.0 |
Genes, BRCA1 | 2 | 1.0 |
Disease Models, Animal | 3 | 0.0 |
